Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+16.05%
-12.55%
-15.72%
-2.98%
OCUL
Ocular Therapeutix Inc.
$11.79
Login to see Ocular Therapeutix Inc. (OCUL) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Upgraded on attractively valued
Outperform the market
Chart
$12.44 (-5.23%)
$11.52 (+2.34%)
$7.3 (+61.51%)
$11.14 (+5.83%)
OCUL has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
OCUL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
OCUL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
OCUL Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayOCUL Earnings
The TTM reflects 12-month period, providing review of OCUL financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is OCUL current stock price?
What are OCUL stock strengths?
What risks are associated with OCUL stock?
When is OCUL next earnings report?
What is OCUL market cap and volume?
What is OCUL's current Stock IQ?
Should I buy OCUL stock right now?
Is OCUL a Strong Buy right now?
What does a 'Strong Buy' rating mean for OCUL?
What does a 'Strong Sell' rating mean for OCUL?
What factors influence OCUL's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+16.05%
-12.55%
-15.72%
-2.98%
OCUL
Ocular Therapeutix Inc.
Current Price
$11.79
Stock Insights
Strengths
Upgraded on attractively valued
Outperform the market
Login to unlock Ocular Therapeutix Inc. (OCUL) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$12.44 (-5.23%)
$11.52 (+2.34%)
$7.3 (+61.51%)
$11.14 (+5.83%)
OCUL Analysts Opinion
OCUL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
OCUL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
OCUL Street view is extremely bullish and have positive views on the near-term outlook
OCUL has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayOCUL Earnings
The TTM data reflects the most recent 12-month period, providing overview of OCUL financial performance.
OCUL Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
OCUL Latest Analysis
HC Wainwright & Co. Maintains Ocular Therapeutix (OCUL) Buy Recommendation. Fintel reports that on October 8 2025 HC Wainwright &. Co. maintained coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Buy recommendation. Analyst Price Forecast Suggests 57.90% Upside
Wed Oct 8, 2025
Baird Maintains Ocular Therapeutix (OCUL) Outperform Recommendation. Fintel reports that on October 3 2025 Baird maintained coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform recommendation. Analyst Price Forecast Suggests 64.47% Upside
Fri Oct 3, 2025
Chardan Capital Maintains Ocular Therapeutix (OCUL) Buy Recommendation. Fintel reports that on October 2 2025 Chardan Capital maintained coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Buy recommendation. Analyst Price Forecast Suggests 64.76% Upside
Thu Oct 2, 2025
Needham Maintains Ocular Therapeutix (OCUL) Buy Recommendation. Fintel reports that on October 1 2025 Needham maintained coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Buy recommendation. Analyst Price Forecast Suggests 64.62% Upside
Thu Oct 2, 2025
Ocular Therapeutix Prices Offering Of 37.9 Mln Common Shares At $12.53/Shr . (RTTNews) - Biopharmaceutical company Ocular Therapeutix Inc. (OCUL) announced Tuesday the pricing of an underwritten offering of 37.9 million shares of its common stock at an offering price of $12.53 per share for gross proceeds of approximately $475.0 million before deducting
Tue Sep 30, 2025
Chardan Capital Initiates Ocular Therapeutix (OCUL) With a Buy Rating. Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the Best Performing Long Term Stocks According to Analysts. On September 15 Daniil Gataulin from Chardan Capital initiated Ocular Therapeutix Inc. (NASDAQ:OCUL) with a Buy rating and a $21 price target. The analyst highlighted the companys Axpaxli program which is the companys lead program and is being gradually [….]
Wed Sep 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
OCUL Stock trends
OCUL Stock performance
OCUL Stock analysis
OCUL investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings
Leaders